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ABSTRACT The structural and fusogenic properties of large unilamellar vesicles (LUVs) composed of the cationic lipid
N-[2,3-(dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA) and 1,2-dioleoyl-3-phosphatidylethanolamine
(DOPE) have been examined in the presence of pCMV5 plasmid and correlated with transfection potency. It is shown,
employing lipid mixing fusion assays, that pCMV5 plasmid strongly promotes fusion between DOTMIADOPE (1:1) LUVs and
DOTMA/1,2-dioleoyl-3-phosphatidylcholine (DOTMA/DOPC) (1:1) LUVs such that at a cationic lipid-to-DNA charge ratio of
3.0, -80% fusion is observed. The anions citrate and chloride can also trigger fusion, but at much higher concentrations.
Freeze-fracture electron microscopy studies demonstrate the tendency of cationic vesicles to form clusters at low pCMV5
content, whereas macroscopic fused aggregates can be observed at higher plasmid levels. 31p NMR studies of the fused
DNA-DOTMA/DOPE (1:1) complexes obtained at high plasmid levels (charge ratio 1.0) reveal narrow "isotropic" 31p NMR
resonances, whereas the corresponding DOPC containing systems exhibit much broader "bilayer" 31p NMR spectra. In
agreement with previous studies, the transfection potency of the DOPE-containing systems is dramatically higher than for the
DOPC-containing complexes, indicating a correlation between transfection potential and the motional properties of endog-
enous lipids. Interestingly, it was found that the complexes could be separated by centrifugation into a pellet fraction, which
exhibits superior transfection potencies, and a supernatant fraction. Again, the pellet fraction in the DOPE-containing system
exhibits a significantly narrower 31 p NMR resonance than the corresponding DOPC-containing system. It is suggested that
the 31P NMR characteristics of complexes exhibiting higher transfection potencies are consistent with the presence of
nonbilayer lipid structures, which may play a direct role in the fusion or membrane destabilization events vital to transfection.
INTRODUCTION
Liposomes composed of equimolar mixtures of N-[2,3-
(dioleyloxy)propyl]-N,N,N-trimethylammonium chloride
(DOTMA) and 1,2-dioleoyl-3-phosphatidylethanolamine
(DOPE) can act as agents that mediate intracellular delivery
of plasmid DNA into cells. This has been shown to result in
efficient transgene expression in vitro (Felgner et al., 1987,
1989; Lu et al., 1989; Pinnaduwage et al., 1989; Jarnagin et
al., 1992) and limited transgene expression in vivo (Nabel et
al., 1992; Zhu et al., 1993; Egilmez et al., 1996). In these
systems, plasmid DNA is mixed with preformed small
unilamellar vesicles (SUVs) or large unilamellar vesicles
(LUVs) to form DNA-lipid complexes that interact, in turn,
with target cells (Friend et al., 1996). Considerable effort
has been made to characterize the structure of these com-
plexes to identify characteristics that correspond to most
efficient intracellular delivery of plasmid and subsequent
gene expression. Most of these investigations have focused
on the morphological features of the complexes as deter-
mined by various microscopic techniques, including metal
shadowing electron microscopy (EM) (Gershon et al., 1993;
Zabner et al., 1995), freeze-fracture EM (Stemnberg et al.,
1994), cryo-transmission EM (Gustafsson et al., 1995), and
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atomic force microscopy (Wheeler et al., 1996). Little con-
sensus has been reached on relating structures observed to
transfection activity.
Less attention has been paid to the relations between the
fusogenic and motional properties of DNA-cationic lipid
complexes and transfection potency. Fusion events are
clearly integral to the formation of the complexes them-
selves as well as to the subsequent intracellular delivery of
DNA. The motional properties of lipids as detected by NMR
techniques can give insight into local structure that can be
correlated with fusogenic and transfection behavior. In this
work, we examine the structural, motional, and fusogenic
properties of DOTMA/DOPE LUVs on the addition of
pCMV5 plasmid, and correlate this information with trans-
fection potential. It is shown that plasmid DNA is a highly
potent promoter of fusion between DOTMA/DOPE (1:1)
LUVs, forming structures characterized by narrow 31p
NMR signals characteristic of rapid, isotropic motional av-
eraging. It is suggested that the lipid structures giving rise to
this behavior may correspond to nonbilayer lipid arrange-
ments, which facilitate the fusion events associated with
transfection by DNA-cationic lipid complexes.
MATERIALS AND METHODS
Lipids and chemicals
1,2-Dioleoyl-3-phosphatidylcholine (DOPC), 1,2-dioleoyl-3-phosphati-
dylethanolamine (DOPE), 1,2-dioleoyl-3-phosphatidylserine (DOPS), N-
(7-nitro-2, 1,3-benzoxadiazol-4-yl)- 1,2-dioleoyl-sn-phosphatidylethano-
lamine (NBD-PE), and N-(lissamine rhodamine B sulfonyl)-1,2-dioleoyl-
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sn-phosphatidylethanolamine (Rh-PE) were obtained from Avanti Polar
Lipids (Alabaster, AL). 3-(N,N-Dimethylamino)-1,2-propanediol, potas-
sium hydride, and iodomethane (methyl iodide) were purchased from
Aldrich Chemical Co. (Milwaukee, WI). Magnesium sulfate (MgSO4),
,B-mercaptoethanol, potassium acetate, potassium chloride, sodium chlo-
ride, anhydrous sodium sulfate, sodium phosphate, sodium hydroxide,
glacial acetic acid, and citric acid were obtained from Fisher Scientific
(Fair Lawn, NJ). Ampicillin, bovine serum albumin (BSA), 1-bromo-cis-
9-octadecene (oleyl bromide), EDTA, HEPES, lithium chloride, lysozyme,
polyethyleneglycol (PEG 8000), ribonuclease A (RNase), t-octylphenoxy-
polyethoxyethanol (Triton X-100), sodium dodecyl sulfate, and tris(hy-
droxymethyl)aminomethane (Tris) were obtained from Sigma Chemical
Co. (St. Louis, MO). '4C-labeled cholesteryl hexadecyl ether ([14C]CHOL-
HEX) was purchased from Dupont NEN Products (Boston, MA). Chloro-
phenol red galactopyranoside (CPRG) was purchased from Boehringer
Mannheim (Germany). Deuterium oxide was obtained from MSD Isotopes
(Montreal, ON). All organic solvents were purchased from Fisher Scien-
tific (Nepeau, ON). Freon 22 was obtained from Allied Chemical Ltd.
(Mississauga, ON). Silica gel 60 (particle size 63-200 ,um, 70-230 mesh)
was purchased from VWR Scientific (Edmonton, AL). Agarose was pur-
chased from Bio-Rad (Richmond, CA). Glycerol and glucose were ob-
tained from BDH (Toronto, ON). Dulbecco's modified Eagle medium
(DMEM), fetal bovine serum (FBS), penicillin-streptomycin, and EcoRI
were purchased from Gibco BRL (Burlington, ON). Baby hamster kidney
(BHK) cells (BHK 21) were obtained from the American Tissue Culture
Collection (ATCC CCL-10). Distilled water was purified from a Coming
Mega-Pure MP-4S system.
Synthesis of DOTMA
DOTMA was synthesized as described previously (Felgner et al., 1987), by
the following modified procedure. A mixture of 3-(dimethylamino)-1,2-
propanediol (0.92 g, 1.49 mmol), potassium hydride (0.36 g, 3.14 mmol),
and oleyl bromide (1.50 g, 4.48 mmol) in xylenes (20 ml) was stirred at
room temperature and reduced pressure (30 mm Hg) for 30 min. After the
mixture was heated to 500C with a condenser and continuously stirred for
an additional 15 min, the mixture was heated to reflux under continuous
nitrogen flow at atmospheric pressure for 4 h. After the mixture was cooled
and hexane (150 ml) was added, distilled water (150 ml) was added
dropwise to the mixture. The reaction mixture was then extracted until
neutrality was reached. After the organic layer was dried with anhydrous
sodium sulfate, the crude intermediate product was concentrated under
rotary evaporation and was purified with a silica gel column, with stepwise
elution of 2:1 diethyl ether/hexane and then 4:2:1 diethyl ether/hexane/
ethanol. The intermediate product, 2,3-dioleyloxy-1-(dimethylamino)pro-
pane, was obtained as a colorless oil (0.55 g, 60% yield; TLC, Rf = 0.40
with 4:2:1 diethyl ether/hexane/ethanol), and the structure was confirmed
by 200 MHz 'H NMR. The final product was prepared by stirring the
intermediate product (0.42 g, 0.67 mmol) with methyl iodide (0.68 g, 4.79
mmol) in dichloromethane (40 ml) for 20 h in the dark. After rotary
evaporation, the residue was dissolved in 60 ml dichloromethane and was
repeatedly extracted with aliquots of 40 ml 1.0 M NaCl until the iodide
form of DOTMA (TLC, Rf = 0.35 with 6:1 dichloromethane/methanol)
was converted into the chloride form of DOTMA (TLC, Rf = 0.22 with 6:1
dichloromethane/methanol). Column chromatography on silica gel and
eluting with 1:1 hexane/ethanol and then 6:1 dichloromethane/methanol
gave 0.30 g (67% yield) of pure product. The structure of DOTMA was
confirmed by 200 MHz 'H NMR and low-resolution-power liquid second-
ary ion mass spectroscopy (Kratos Concept II H) with a parent ion mass of
635 atomic mass units.
Plasmid
Plasmid DNA (pCMV5) (Andersson et al., 1989) was grown in Esche-
richia coli (DH5a) and was selected by resistance to ampicillin. pCMV5
was isolated by alkali lysis and purified by polyethylene glycol (PEG)
precipitation (Sambrook et al., 1989). Briefly, 3.0 liters of saturated bac-
terial cultures was collected by centrifugation and resuspended in 108 ml
of 50 mM glucose, 25 mM Tris-Cl (pH 8.0), 10 mM EDTA. After the
addition of a tip-in spatula of solid lysozyme, and then 240 ml of freshly
prepared 0.20 M NaOH/1% sodium dodecyl sulfate with gentle mixing for
15 min, 180 ml of ice-cold 5.0 M potassium acetate/glacial acetic acid/
distilled water was distributed evenly in the lysate, which was then cooled
in ice for 15 min, centrifuged at 5000 rpm for 30 min, and filtered through
a layer of cheesecloth. An equal volume of isopropanol was added to the
supernatant for precipitation. After centrifugation, the pellet was rinsed
with 70% ethanol and resuspended in 18 ml TE (10 mM Tris-Cl, pH 8.0,
1 mM EDTA). An equal volume of ice-cold 5.0 M LiCl was then added for
precipitation; and an equal volume of isopropanol was added to the
resulting supematant for reprecipitation. The resulting pellet was washed
with 70% ethanol and was resuspended in 3.0 ml TE with 100 ,ul DNase-
free pancreatic RNase (10 mg/ml) for 2 h at room temperature. Three
milliliters of 1.6 M NaCl with 13% (w/v) PEG 8000 was added, and the
plasmid was recovered by centrifugation at 11,000 X g for 5 min. The
pellet was extracted once with phenol, once with phenol/chloroform, and
once with chloroform. The aqueous layer was treated with 600 ,ul 3.0 M
sodium acetate and two volumes of ethanol. The precipitated plasmid was
washed with 70% ethanol and was resuspended in distilled water. The
purity of pCMV5 was confirmed by 1% agarose gel electrophoresis with
restriction endonuclease EcoRI digest. Because one nucleotide contains
only one phosphate group, the concentration ofpCMV5 was determined by
using standard phosphorus assays (Fiske and Subbarow, 1925) and was
expressed as the phosphorus concentration of pCMV5. A similar procedure
was used for the preparation of pCMV,3gal.
Preparation of LUVs
Mixtures of lipids dispensed in chloroform were dried under a stream of
nitrogen gas with continuous vortex mixing. The residual solvent was
removed under high vacuum for 2 h. The resulting lipid films were
hydrated with appropriate buffers and then freeze-thawed five times to
produce homogeneous multilamellar vesicle systems (MLVs). Large unila-
mellar vesicle systems (LUVs) were obtained by extruding MLVs 10 times
through two 100-nm pore size polycarbonate filters (Costar Nuclepore
polycarbonate membrane) under nitrogen at a pressure of 300-400 psi
(Mayer et al., 1986). The size of LUVs was checked with a Nicomp model
270 submicron particle sizer, using quasielastic light scattering techniques.
Phosphorus assays were used to quantify phospholipid concentration
(Fiske and Subbarow, 1925).
Lipid-mixing fusion assay
Fusion was determined by the decrease in resonance energy transfer (RET)
resulting from fluorescent probe dilution (Struck et al., 1981). The ex-
change of labeled lipids between two populations of vesicles, even in
aggregated systems, has been reported to be negligible (Hoekstra, 1982).
LUVs of the desired composition were prepared in 20 mM HEPES (pH
7.4) and were diluted to 10 mM total lipid. Fluorescently labeled LUVs of
DOTMA/DOPE (1:1) or DOTMA/DOPC (1:1) containing 0.5 mol% each
of NBD-PE and Rh-PE were prepared similarly. For the fusion assays used
to study the effects of NaCl, citrate, and pCMV5 on DOTMA/DOPE (1:1)
and DOTMA/DOPC (1:1) LUVs, a mixture of labeled and nonlabeled
LUVs (1:9) was prepared. Then 100 ,ul of the mixed LUVs was added to
1850 ,ul of 20 mM HEPES (pH 7.4) in a cuvette with continuous stirring,
and the fluorescence intensity (F) was monitored over time. Fusion was
induced by the addition of 50 ,ul of appropriate anions at 30 s. Excitation
and emission wavelengths were 445 nm and 535 nm, respectively, and a
530-nm emission cutoff filter was used. A blank assay with 50 ,pl of 20
mM HEPES (pH 7.4) was used as a reference for zero fluorescence (FO).
The maximum fluorescence intensity (Fmax) was measured by the addition
of 40 ,ul 4% Triton X-100. A mock complete mixing system of LUVs
containing 0.05 mol% each of fluorescent probes was also prepared. The
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fluorescence intensity before (Fb) and after (Fa) the addition of 40 ,ul 4%
Triton X-100 in this mock sample was taken into consideration when the
percent change in fluorescence (% AF/AFmax) was calculated for each
point in the fluorescence time course.
% AF/AFmax= {[(F - Fo)/(Fmax - Fo)]100}(FdFa) (1)
For the study of fusion of DOTMA/DOPE or DOTMA/DOPC LUVs with
DOPS systems, 10 ,ul of fluorescently labeled DOTMA/DOPE (1:1) or
DOTMA/DOPC (1:1) LUVs (10 mM total lipid) was added to 1940 ,gl of
20 mM HEPES (pH 7.4) in a cuvette with continuous stirring. At 30 s, 50
,ul of the appropriate composition of nonlabeled DOPS/DOPE or DOPS/
DOPC LUVs (10 mM total lipid) was added to induce fusion. Mock
samples for different compositions containing 0.083 mol% each of fluo-
rescent probes were prepared. An assay of 50 ,ul of 20 mM HEPES (pH
7.4) was used for zero fluorescence (F0u), and the fluorescence of the
appropriate mock samples was taken to be the maximum fluorescence
(Fmax). The percentage change in fluorescence was then calculated as
% AF/AFmax = [(F - Fnu)/(Fmax - Fn)]100 (2)
for each point in the fluorescence time course. For studying the interaction
between the DNA-lipid complexes and anionic model membrane system,
10 ,ul of fluorescently labeled DOTMA/DOPE (1:1) or DOTMA/DOPC
(1:1) LUVs (10 mM total lipid) was added to 1890 ,ul of 20 mM HEPES
(pH 7.4) in a cuvette with continuous stirring. An aliquot of 50 ,ul of serial
diluted pCMV5 stocks was added at 30 s in each assay. At 90 s, 50 ,u1 of
10 mM nonlabeled DOPS/DOPE (1:1) or DOPS/DOPC (1:1) LUVs was
added. The data processed from this experiment was right-shifted for 60 s
(i.e., time 0 was taken to be the 60-s time point). The fluorescence intensity
obtained after the addition of pCMV5 to the labeled LUVs was taken as the
reference for each assay (Fnu). The maximum fluorescence intensity (Fmax)
was measured by the addition of 25 ,ul 4% Triton X-100. A mock sample
of LUVs containing 0.083 mol% each of fluorescent probes was used, and
the % AF/AFmax was calculated as
% AFAFma= {[(F -Fnu)/(Fmax - Fnu)]100}(Fb/Fa) (3)
for each point in the fluorescence time course. All fusion assays were
performed at 25°C.
31p NMR spectroscopy
Solid-state broad-band decoupling 31P NMR spectra were recorded at
81.02 MHz on a Bruker MSL 200 spectrometer, using a 4.0-p.s pulse and
a 1.5-s repeat time. The free induction decay (FID) was accumulated over
1500-2000 scans and was Fourier transformed with 50-Hz line broaden-
ing. For studies showing the effect of DOTMA on DOPE, various com-
positions of freeze-thawed DOTMA/DOPE (50 ,umol, 33 mM DOPE)
MLVs were hydrated in 20 mM HEPES/D20 (pH 7.4). The temperature
was controlled with a Bruker variable temperature 1000 unit at settings
with increments of 10'C. The temperature under 40°C was controlled with
a liquid nitrogen flow system; the temperature above 40°C was maintained
with a nitrogen gas flow system. For the experiments showing the effects
of different anions on DOTMA/DOPE or DOTMA/DOPC systems, sam-
ples of DOTMA/DOPE (1:1) or DOTMA/DOPC (1:1) (50 ,umol each, 100
mM total lipid) LUVs in 20 mM HEPES/D2O (pH 7.4) were prepared as
described earlier. Then the sequential addition of appropriate amounts of
different anions to each sample was used to induce changes in lipid
organization. Temperature was maintained at 25°C with a liquid nitrogen
flow system. The FIDs of the resuspended pellet and supematant of
DNA-cationic lipid complexes were accumulated over 10,000-20,000
scans. For the separation of DNA-cationic lipid complexes, the appropriate
amount of plasmid DNA was added to a population of LUVs prepared in
20 mM HEPES. The mixture was centrifuged at 11,000 X g in a Sorvall
RC-SB superspeed centrifuge for 15 min. The pellet was twice washed with
distilled water and centrifuged before resuspending in 20 mM HEPES/
D20. All 31P NMR spectra were locked with D20. A mixture of phosphoric
acid/D20 was used as the reference for chemical shifts in all 31P NMR
spectra.
Freeze-fracture electron microscopy
Samples of DOTMA/DOPE (1:1) and DOTMA/DOPC (1:1) (30 mM total
lipid) LUVs in 20 mM HEPES (pH 7.4) were prepared as described earlier.
Fifty-milliliter aliquots of lipid sample were titrated with the appropriate
amount of NaCl, citrate, or pCMV5. After incubation at room temperature
for 15 min, 33.5 j,l of glycerol was added as a cryoprotectant to make a
final glycerol level of 25% by volume in each sample. The final concen-
tration of total lipid in each sample was 11 mM (0.75 ,umol each of
DOTMA and DOPE or DOPC). After physical mixing and incubating for
another 15 min, a 2.0-j,l droplet of the sample was pipetted onto a flat-top
gold support disc, which was then plunged into liquid nitrogen-cooled
liquid freon 22 (monochlorodifluoromethane; freezing point - 160°C).
After 5 s, the sample was transferred to a specimen table immersed in
liquid nitrogen before insertion into the freeze-fracture apparatus (Balzers;
BAF400D). Fracturing was performed at -110°C with a vacuum of 10-6
to 10-7 torr. Immediately after the fracturing, a 2-nm coating of platinum-
carbon at an angle of 450 and then a 20 nm coating of carbon at an angle
of 900 were applied. The gold cup was then warmed to room temperature
and was submerged in distilled water for replica removal. Replicas were
cleaned overnight in commercial bleach solution and were rinsed two times
with distilled water before mounting on a grid by using a platinum transfer
loop. The dried replicas were examined under a transmission electron
microscope (Jeol; JEM-1200EX).
Separation and quantification of DNA/cationic
lipid complexes
DNA-cationic lipid complexes were formed by incubating appropriate
amounts of preformed cationic vesicles with 20 ,ug pCMVI3gal to obtain
the desired charge ratio (±) in 250 ,ul distilled water. Trace amounts of
[3H]pCMV,Bgal and ['4C]CHOL-HEX were used as markers. The resulting
mixture was incubated at room temperature for 15 min and was then
centrifuged at 11,000 X g in a Sorvall MC-12V microcentrifuge for 15
min. The supernatant was pipetted out for storage, and the pellet was
resuspended in 250 ,ul distilled water. Mock samples for each charge ratio
without centrifugation were also prepared. Aliquots of 50 p.l from samples
of the pellet and the supernatant were counted for radioactivity and were
compared with mock samples for the percentage of [3H]DNA and
[14C]lipid recovery, respectively.
In vitro DNA transfection on BHK cells
All DNA transfection procedure was carried out in a laminar flow hood
(Forma Scientific). DNA-cationic lipid complexes were prepared as de-
scribed above, except that 0.5 ,ug of pCMV,Bgal was used for each
transfection preparation. Appropriate amounts of vesicles were used for
each charge ratio. Triplicates of transfection samples were prepared simul-
taneously. Standards of (3-galactosidase were prepared by twofold serial
dilutions of 200 milliunits of (3-galactosidase with 0.5% bovine serum
albumin (BSA) in phosphate-buffered saline (PBS) (pH 8.0). A unit of
,B-galactosidase will hydrolyze 1.0 ,umol of o-nitrophenyl-f3-D-galactoside
to o-nitrophenol and D-galactose per minute at pH 7.3 at 37°C. A similar
transfection protocol has been published elsewhere (Felgner et al., 1994).
First, BHK cells (BHK 21) cultured in DMEM with 10% FBS and 100
units of penicillin and 100 ,ug streptomycin as antibiotics were plated onto
a 96-well microtiter plate with 2 X 104 cells per well. The plate was then
incubated for 20 h at 37°C with 5% carbon dioxide. Wells for standards
were not plated. For each well, appropriate amounts of DNA-lipid com-
plexes (preformed for 30 min) were diluted with DMEM/FBS. Aliquots of
100 ,ul of DNA-lipid complexes were plated and the resulting plate was
incubated at 37°C, 5% CO2 for 4 h. After the removal of the transfected
media, 100 ,ul of DMEM/FBS was added, and cells were further incubated
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for 20 h at 37°C, 5% Co2. Cells were lysed by adding 50 ,ul of lysis buffer
containing 0.1% Triton X-100 in 250 mM phosphate buffer (pH 8.0) and
were left at -70°C for -30 min to ensure complete lysis. After thawing,
50 ,ul of PBS containing 0.5% BSA or 50 ,ul of the appropriate j-
galactosidase standard was added. Color development was induced by
adding 150 ,ul of substrate buffer containing chlorophenol red galactopy-
ranoside (CPRG) (1 mg/ml), 60 mM Na2HPO4, 1 M MgSO4, 10 mM KCI,
and 50 mM ,B-mercaptoethanol, and was measured at 540 nm with a
microplate EL-309 autoreader (Bio-Tek Instruments). For the transfection
of samples from the resuspended pellet and the supernatant of DNA-lipid
complexes after centrifugation at 11,000 X g, trace amounts of
[3H]pCMV,3gal and [14C]CHOL-HEX were included for quantification.
RESULTS
DOTMA can stabilize DOPE into a
bilayer organization
The effect of DOTMA on the structural behavior of DOPE
in aqueous dispersions of mixtures of DOTMA and DOPE
was investigated by 31P NMR techniques. DOTMA/DOPE
dispersions with increasing DOTMA content (from 0% to
80%) were prepared in 20 mM HEPES buffer (pH 7.4). For
each sample, 31P NMR spectra were recorded from 10°C to
70°C in increments of 10°C. As shown in Fig. 1, at both
200C and 400C, aqueous dispersions of pure DOPE exhibit
a typical hexagonal (HI,) phase 31P NMR signal (Cullis and
de Kruijff, 1979), which is characterized by a high field
shoulder and a low field peak, where the separation between
the shoulder and peak is about half of that observed for the
bilayer 31P NMR signal. As the DOTMA content increases,
an increased bilayer 31P NMR component, characterized by
a high field peak and a low field shoulder, is observed.
DOPE was partially stabilized into a bilayer organization at
temperatures up to 20°C in the presence of 20% DOTMA,
A B
80%
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0%
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FIGURE 1 31P NMR spectra of freeze-thawed DOTMA/DOPE MLVs in
20 mM HEPES (pH 7.4) with increasing DOTMA content (0%, 20%, 50%,
and 80%) at (A) 20°C and (B) 40°C. Sample preparation and NMR
parameters are described in Materials and Methods.
whereas at 50% DOTMA content, DOPE was stabilized into
a bilayer organization up to 60°C. With an 80% DOTMA
content, bilayer organization was observed over the entire
temperature range studied. Thus for a DOTMA/DOPE (1:1)
system, which is the composition of the commercially avail-
able Lipofectin reagent, DOPE is stabilized into a bilayer
organization at both room and physiological temperatures.
The ability of DOTMA to stabilize DOPE into a bilayer
organization is similar to the ability of lipids such as phos-
phatidylcholine (PC) as well as anionic phospholipids such
as phosphatidylserine (PS) to stabilize PE into a bilayer
organization (Cullis and de Kruijff, 1979).
pCMV5 can trigger membrane fusion between
DOTMA/DOPE LUVs
The ability of equimolar amounts of DOTMA to stabilize
DOPE into a bilayer organization allows stable large unila-
mellar vesicles to be made. The addition of plasmid DNA
results in formation of the DNA-lipid complexes used for
transfection. It is of interest to examine the fusogenic be-
havior of DOTMA/DOPE (1:1) LUVs in response to the
presence of plasmid DNA. This was done with the lipid
mixing assay detailed in Materials and Methods. DOTMA/
DOPE (1:1) LUVs containing 0.5 mol% each of NBD-PE
and Rh-PE and nonlabeled 1:1 DOTMA/DOPE vesicles
were prepared. When the labeled vesicles fuse with nonla-
beled vesicles, dilution of the fluorescent probes results in
an increase in NBD-PE fluorescence. Fusion between
DOTMA/DOPE LUVs on the addition of pCMV5 plasmid
is shown in Fig. 2 A. The number beside the fluorescence
profile is the cation-to-anion charge ratio. For the titration of
pCMV5, the charge ratio is determined as moles of
DOTMA/moles of phosphorus in the plasmid. As the
pCMV5 content increases, increased fusion is observed.
A comparison between plasmid-induced fusion and that
induced by other anions is provided in Fig. 2, B and C. For
the titration of citrate and NaCl, the number beside each
fluorescence profile is the respective anion concentration.
To achieve 80% fusion at 3.5 min after the addition of
anions, a phosphorus concentration ofpCMV5 of 0.063 mM
(charge ratio = 3.0) is required; whereas 0.93 mM citrate
carboxyl (charge ratio = 0.20) and 800 mM NaCl (charge
ratio = 2.3 X 10-4) are required. Thus, on a per-molecule
basis, pCMV5 is -5.0 x 104-fold more effective at induc-
ing membrane fusion between 1:1 DOTMA/DOPE LUVs
than citrate, which in turn is about 2.7 X 103-fold more
effective than NaCl.
Addition of pCMV5 to DOTMA/DOPE (1:1) LUVs
causes the formation of large lipid structures
characterized by isotropic motional averaging
The structural characteristics of the DNA-cationic lipid
complexes are of obvious interest. 31P NMR was used to
identify the behavior of DOPE in the complexes; and
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FIGURE 2 Effect of (A) pCMV5 plasmid, (B) citrate, and (C) NaCl on
fusion of DOTMA/DOPE (1:1) vesicles in 20 mM HEPES (pH 7.4) at
25°C. Vesicles were prepared with and without 0.5 mol% each of NBD-PE
and Rh-PE. The labeled and unlabeled vesicles were mixed in a 1:9 ratio
and diluted to 0.38 mM total lipid. Different anions were added at 30 s. The
concentration of citrate and NaCl (mM), and the charge ratio of DNA-
cationic lipid complexes are indicated. The system without DNA is indi-
cated by "n.a." The charge ratio is defined as moles of DOTMA/moles of
phosphorus in pCMV5.
freeze-fracture electron microscopy was used to examine
local structure. As shown in Fig. 3, DOTMA/DOPE (1:1)
LUVs at 250C exhibit a narrow "isotropic" 31P NMR signal
with a peak width at half-height of -7.0 ppm. The addition
of pCMV5 to a charge ratio of 1.0 does not cause significant
broadening (Fig. 3 A). An additional broad 31P NMR signal
with a half-width of -100 ppm was detected beneath this
broad isotropic signal (data not shown). Two lines of evi-
dence indicate that this broad line originated primarily from
plasmid phosphorus. First, the intensity of the narrow 31p
NMR component was not significantly affected by the ad-
_
,, I ........... .,,,
50 0 -50 50 0 -50 50 0 -50
PPM PPM PPM
FIGURE 3 31P NMR spectra of DOTMA/DOPE (1:1) LUVs with se-
quential addition of pCMV5 plasmid (A), citrate (B), and NaCl (C) in
HEPES (10-20 mM; pH 7.4) at 25°C. The charge ratio of DNA-cationic
lipid complexes and the concentration of citrate and NaCl (mM) are
indicated. The system without pCMV5 is indicated by "n.a." The charge
ratio is defined as moles of DOTMA/moles of phosphorus in pCMV5.
dition of plasmid DNA. At the 1.0 charge ratio, for example,
the intensity of the narrow component was -92% of that
observed before the addition of plasmid. Second, the addi-
tion of pCMV5 plasmid to pure DOTMA LUVs (charge
ratio 1.0) resulted in a broad spectral feature with a width of
-100 ppm (data not shown). Thus the observed isotropic
31P NMR signal and particle sizes of microns or larger from
quasielastic light scattering (QELS) measurement indicate
large systems with rapid isotropic motion of the phospho-
lipid. This can correspond to a variety of lipid structures,
including small bilayer vesicles or nonbilayer structures
such as cubic phases (Cullis et al., 1985).
To visualize the structures formed on the addition of
plasmid to DOTMA/DOPE (1:1) LUVs, freeze-fracture EM
studies were performed. In the absence of plasmid, vesicles
with an average size of 100 nm were observed (Fig. 4 A).
When pCMV5 plasmid was added to achieve a ± charge
ratio of 600, the majority of the vesicles remained in dis-
persion (data not shown). At a charge ratio of 20, most
vesicles aggregated into small clusters, with little evidence
of fusion (Fig. 4 B). This is consistent with the 20% lipid
mixing observed employing the fusion assay (Fig. 2 A). At
a charge ratio of 4.0, similar aggregated vesicles fuse into
complexes with sizes ranging from 200 to 1000 nm (Fig. 4
C). Structures that resemble lipidic particles (Verkleij et al.,
1979) arranged in a row were occasionally observed (arrow
1). The observation of large complexes correlates with the
results of the fluorescent fusion assay, in which 80% fusion
was observed at a charge ratio of 3.0 (Fig. 2 A). At charge
ratios of 1.0 and lower, similar aggregates of fused lipid
assemblies were observed (data not shown).
The structural behavior of DOTMA/DOPE LUVs in the
presence of other anions was also examined by 31P NMR.
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FIGURE 4 Freeze fracture electron micrographs of DOTMA/DOPE
(1:1) LUVs in HEPES buffer (10-20 mM, pH 7.4) with different amounts
of pCMV5. DOTMA/DOPE (1:1) LUVs (A) in the absence of pCMV5; (B)
in the presence of pCMV5 (charge ratio of 20); and (C) in the presence of
pCMV5 (charge ratio of 4.0) are shown. The bar on all electron micro-
graphs represents 200 nm and the shadow direction is running from bottom
to top. The original magnification was 20,OOOX.
Titration of DOTMA/DOPE LUVs with chloride and citrate
was performed at pH 7.4, and the respective 3lP NMR
spectra are shown in Fig. 3, B and C. At a high NaCl
concentration of 300 mM, a mixture of bilayer, isotropic,
and HI, signals was observed (Fig. 3 C). The size of the
system increased from -100 nm to -600 nm, as detected
by QELS. The further addition of NaCl (0.7 to 2.0 M)
induced formation of the HII phase. In contrast, mixtures of
bilayer and HII signals were observed in the range of 10-50
mM citrate (Fig. 3 B). Further addition of citrate induces
complete HII structural organization in the DOTMA/DOPE
LUVs.
Addition of pCMV5 to DOTMA/DOPC (1:1) LUVs
causes formation of large bilayer lipid structures
Previous studies have shown that the DOPE "helper" lipid is
essential for efficient transfection employing DNA-cationic
lipid complexes (Leventis and Silvius, 1990; Farhood et al.,
1995). This likely arises from the well-known preference of
DOPE for nonbilayer structures, some of which may play a
direct role in membrane fusion (Cullis et al., 1985; Litzinger
and Huang, 1992). It is therefore of interest to examine the
structural and fusogenic properties of DNA-cationic lipid
complexes in which DOPE is replaced with the bilayer
forming lipid, DOPC. As shown in Fig. 5 A, considerable
fusion was observed when pCMV5 plasmid was added to
DOTMA/DOPC (1:1) LUVs. Compared with DOTMA/
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FIGURE 5 Effect of (A) pCMV5 plasmid, (B) citrate, and (C) NaCl on
fusion of DOTMA/DOPC (1:1) vesicles in 20 mM HEPES (pH 7.4) at
25°C. Vesicles were prepared with and without 0.5 mol% each of NBD-PE
and Rh-PE. The labeled and unlabeled vesicles were mixed in a 1:9 ratio
and diluted to 0.50 mM total lipid. Different anions were added at 30 s. The
concentration of citrate and NaCl (mM), and the charge ratio of DNA-
cationic lipid complexes are indicated. The system without pCMV5 is
indicated by "n.a." The charge ratio is defined as moles of DOTMA/moles
of phosphorus in pCMV5.
DOPE (1:1) LUVs, DOTMA/DOPC (1:1) LUVs require
--1.5-2.0-fold more pCMV5 to obtain the same level of
lipid mixing. In 31P NMR studies, when pCMV5 was added
to DOTMA/DOPC (1:1) LUVs, an isotropic signal was
maintained at charge ratios greater than 8.3; however, at
higher pCMV5 content (lower ± charge ratios), mixtures of
isotropic and bilayer signals were detected (Fig. 6 A).
Again, quasielastic light scattering studies revealed a size
increase to microns or larger at high pCMV5 levels (charge
ratio of 2.2). Freeze-fracture EM studies of these complexes
revealed behavior similar to that of the DOPE-containing
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FIGURE 6 31P NMR spectra of DOTMA/DOPC (1:1) LUVs with the
sequential addition of pCMV5 plasmid (A), citrate (B), and NaCl (C) in
HEPES (10-20 mM; pH 7.4) at 25°C. The charge ratio of DNA-cationic
lipid complexes and the concentration of citrate and NaCl (mM) are
indicated. The system without pCMV5 is indicated by "n.a." The charge
ratio is defined as moles of DOTMA/moles of phosphorus in pCMV5.
systems; however, in the large fused systems obtained at
low charge ratios, structures that could correspond to lipidic
particles were not observed (Fig. 7).
The effects of citrate and chloride on the structural and
fusogenic behavior of DOTMA/DOPC (1:1) LUVs were
also examined. As shown in Fig. 5 B, 103 times as much
citrate in DOTMA/DOPC LUVs is required to induce the
same level of lipid mixing as for DOTMA/DOPE LUVs. No
significant lipid mixing was observed at NaCl concentra-
tions of up to 2.0 M (Fig. 5 C), in agreement with the
observation of an isotropic 31P NMR signal (Fig. 6 C), with
no significant increase in the size of vesicles, as detected by
QELS and freeze-fracture techniques (data not shown).
However, when citrate was added, unusual behavior was
observed. A mixture of bilayer, isotropic, and HI, 31P NMR
signals was detected at 10-100 mM citrate (Fig. 6 B), and
at 150 mM or higher concentrations of citrate, an isotropic
lineshape was observed. The size of the DOTMA/DOPC
(1:1) system in the presence of .150 mM citrate is at least
100-fold larger than that of the untreated vesicles as de-
tected by QELS, again suggesting the formation of cubic or
other nonbilayer structures giving rise to isotropic NMR
spectra.
DOTMA/DOPE LUVs fuse with anionic vesicles
and pCMV5 inhibits such fusion
For transfection to occur, the DNA-cationic lipid complexes
must first fuse with the target cell membrane, which bears a
negative charge due to sialic acid residues in the glycocalyx.
As a simple model for this interaction, fusion between
DOTMA/DOPE (1:1) LUVs or DNA-cationic lipid com-
plexes, and anionic LUVs containing phosphatidylserine
FIGURE 7 Freeze fracture electron micrographs of DOTMA/DOPC
(1: 1) LUVs in HEPES buffer (20 mM, pH 7.4) in the presence of pCMV5
at a charge ratio of 4.0. The bar on the electron micrograph represents 200
nm and the shadow direction is running from bottom to top. The original
magnification was 20,000X.
(PS) was examined. As shown in Fig. 8, no fusion was
observed when DOTMA/DOPE LUVs were incubated with
DOPC LUVs. As the DOPS content was increased to 2
mol% in the DOPS/DOPC LUVs, the amount of fusion with
DOTMA/DOPE LUVs increased considerably. When pure
DOPS LUVs were used, 65% fusion at 3.5 min after addi-
tion was observed. If DOPE was substituted for DOPC in
the DOPS-containing vesicles, the rate and extent of fusion
increased markedly (data not shown).
The influence of pCMV5 on fusion between cationic and
anionic LUVs is illustrated in Fig. 9. In these experiments,
the fluorescently labeled DOTMA/DOPE LUVs were first
mixed with pCMV5, and the complexes were then incu-
bated with nonlabeled DOPS/DOPC (1:1) vesicles. When
no pCMV5 plasmid was present, 60% fusion was observed;
however, at higher pCMV5 levels corresponding to charge
ratios of 0.91 or smaller, fusion was markedly inhibited.
Fusion of the same complexes with DOPS/DOPE (1:1)
LUVs showed similar behavior. In the absence of plasmid,
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FIGURE 8 Fusion of DOTMA/DOPE (1:1) LUVs with various compo-
sitions of DOPS/DOPC LUVs in 20 mM HEPES (pH 7.4) at 25°C. The
percentage of DOPS content in each vesicle system is indicated. Fusion
assays were carried out as described in Materials and Methods.
80% fusion was observed; whereas the presence of pCMV5
at a charge ratio of 1.0 reduced the fusion index to 60%, and
only 5% fusion was observed at a charge ratio of 0.83 (data
not shown).
Complexes formed by the addition of plasmid
DNA to cationic LUVs can be separated into two
fractions by centrifugation
In an attempt to understand the origin of the isotropic 31p
NMR resonance observed for pCMV5-DOTMA/DOPE
(1:1) at a charge ratio of 1.0 (Fig. 3), the complexes were
separated into two fractions by centrifugation. Briefly, it
was reasoned that the dispersion may consist of a dense
DNA-rich fraction and vesicles with little associated DNA
that make a dominant contribution to the narrow 31P NMR
signal. As shown in Fig. 10, centrifugation of the
pCMV,Bgal containing complexes at 11,000 X g for 15 min
resulted in a proportion in the pellet that was sensitive to the
charge ratio. The maximum amount of lipid and DNA in the
pellet fraction appears in the region with a charge ratio of
120
100
i 80
'S40
p 20
-0
-20
n.a.
1.1
0.91
0.20
Time (s)
FIGURE 9 Fusion of pCMV5-DOTMA/DOPE (1:1) complexes with
DOPS/DOPC (1:1) LUVs in 20 mM HEPES (pH 7.4) at 25°C. A 0.024
mM DOTMA concentration was used in each assay. Fusion assays were
carried out as described in Materials and Methods. The charge ratio of each
system is indicated and is defined as moles of DOTMA/moles of phos-
phorus in pCMV5. The system without pCMV5 is indicated by "n.a."
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FIGURE 10 DNA and lipid recovery in supematant and pellet fractions
after centrifugation of DNA-cationic lipid complexes. Trace amounts of 3H
pCMV,Bgal and 14C CHOL-HEX, and 20 ,ug pCMV,Bgal were used for
both pCMVf3gal-DOTMA/DOPE (A) and pCMVf3gal-DOTMA/DOPC
(B). DNA (0, *) and lipid (O, *) recovery in the supernatant (-- -) and
the resuspended pellet fractions ( ) are shown. The charge ratio is
defined as moles of DOTMA/moles of phosphorus in pCMV,3gal.
1.0. Contrary to expectation, there was no evidence for a
DNA-rich pellet; the lipid and DNA were separated in
approximately equal proportions into the pellet and super-
natant. It is therefore probable that the pellet and superna-
tant fractions differ in size rather than in density, with the
larger complexes contributing the pellet fraction. Notably,
when DOPC was substituted for DOPE, the pellet fraction
was increased to over 90% of the lipid and plasmid as
compared to 50% for the DOPE-containing system.
The 31P NMR characteristics of the pellet and supematant
at a charge ratio of 1.0 for both DOPE- and DOPC-contain-
ing complexes are shown in Fig. 11. The supernatant 31p
NMR peak remains narrow in both cases. As may be ex-
pected, the 31P NMR resonance for the pellet fractions is
broader; however, the resonance observed for the pellet
obtained from the DOPE-containing system is again sub-
stantially narrower than the bilayer lineshape derived from
the DOPC-containing system. Similar 31P NMR phenomena
were observed for both pCMV5- and pCMV,gal-contain-
ing complexes (data not shown).
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FIGURE 11 31P NMR spectra of pCMV5-cationic lipid complexes at a
charge ratio of 1.0 in HEPES buffer (20 mM; pH 7.4) at 25°C. 31P NMR
spectra are shown for the supematant (A, C) and the pellet fractions (B, D)
of pCMV5-DOTMA/DOPE complexes (A, B) and pCMV5-DOTMA/
DOPC complexes (C, D) after centrifugation for 15 min at 11,000 x g. The
charge ratio is defined as moles of DOTMA/moles of phosphorus in
pCMV5.
The transfection potency of pCMV.Bgal-DOTMA/
DOPE (1:1) complexes correlate with the
pellet fraction
The relation between the structural and motional properties
of the DNA-cationic lipid complexes and their ability to
transfect target cells is of obvious importance. The trans-
fection of BHK cells employing pCMV,Bgal-DOTMA/
DOPE (1:1) complexes at various charge ratios is illustrated
in Fig. 12. It may be observed that maximum transfection is
observed at a charge ratio of 1.0, in agreement with previous
studies (Gao and Huang, 1991; Felgner et al., 1994). No
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transfection was observed at charge ratios below 1.0; and
the levels of transfection decrease to background levels at
charge ratios greater than 4.0. The importance of DOPE as
a "helper" lipid is clear, again in agreement with previous
studies (Felgner et al., 1987, 1994; Farhood et al., 1995), as
no significant transfection is observed when DOPC is sub-
stituted for DOPE. No transfection was observed in the
absence of plasmid or lipid.
The next set of transfection studies examined the relative
transfection potencies of the pellet and supernatant frac-
tions. Remarkably, as shown in Fig. 13, the pellet fractions
containing large complexes exhibited significantly greater
transfection potency than the unfractionated complex or the
supernatant fractions. Interestingly, the reduction in trans-
fection potency of the unfractionated complexes at higher
charge ratios (Fig. 12) corresponds approximately to the
amount of material that can be pelleted by centrifugation
(Fig. 10).
DISCUSSION
This investigation was focused on characterizing the struc-
tural, motional, and fusogenic properties ofDOTMA/DOPE
systems in isolation and in the presence of plasmid DNA.
There are three major points of interest in the results ob-
tained. These concern the ability of plasmid DNA and other
multivalent anions to induce fusion between cationic LUVs,
the structural and motional features of the complexes
formed, and the relation between these features and trans-
fection potential. We discuss these areas in turn.
The ability to form DOTMA/DOPE LUVs relies on the
ability of the cationic lipid DOTMA to stabilize DOPE into
a bilayer organization, which is similar to the ability of
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FIGURE 12 Transfection of BHK cells by pCMV,3gal-cationic lipid
complexes at various charge ratios. Triplicate results are shown for the
transfection of pCMV/3gal-DOTMA/DOPE (1:1) complexes (-) and
pCMV,3gal-DOTMA/DOPC (1:1) complexes (El) on BHK cells, as deter-
mined by the ,3-galactosidase assay described in Materials and Methods.
The charge ratio is defined as moles of DOTMA/moles of phosphorus in
pCMV,Bgal. Transfection by "naked" pCMV,Bgal is indicated by column D.
FIGURE 13 Transfection of BHK cells by fractionated and unfraction-
ated DNA-cationic lipid complexes obtained by centrifugation. Triplicate
results are shown for the transfection of the unfractionated pCMVf3gal-
DOTMA/DOPE (1:1) complexes (-), the pellet fractions (R), and the
supernatant fractions (LI) at charge ratios (±) of 1.0, 1.5, and 2.0, as
determined by the f3-galactosidase assay described in Materials and Meth-
ods. No transfection was observed in the presence of "naked" pCMV,Bgal.
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anionic phospholipids, such as phosphatidylserine (PS), to
stabilize DOPE into the bilayer phase (Cullis and de Kruijff,
1979). Furthermore, the ability of polyanions such as plas-
mid DNA to trigger fusion between DOTMA/DOPE (1:1)
LUVs is analogous to the ability of mono- and divalent
cations to trigger fusion between PS/PE vesicles, as dem-
onstrated extensively elsewhere (Tilcock and Cullis, 1981;
Bally et al., 1983; Hope et al., 1983; Duzgunes and Papa-
hadjopoulos, 1983; Duzgunes et al., 1987). The mechanism
whereby divalent cations such as Ca2+ can induce fusion in
these systems has been shown to arise primarily from ef-
fects related to the neutralization of the surface charge due
to the anionic lipid rather than lateral segregation of the
anionic species into local domains, although lateral segre-
gation can occur in certain situations (Tilcock et al., 1984).
Neutralization of the surface charge leads to a reduced
effective headgroup size of the charged lipid species and
correspondingly reduced ability to stabilize the bilayer or-
ganization. In addition, this reduced surface charge leads to
reduced intervesicular electrostatic repulsion, thus promot-
ing the aggregation step required for fusion. It is likely, but
not proven, that the ability of plasmid to induce fusion in the
DOTMA/DOPE LUVs investigated here is also due to
charge neutralization effects, as there is no evidence of
lateral segregation of DOTMA. Two observations support
this. First, the only situation giving rise to lateral phase
separation of PS in PS/PE systems arises because of segre-
gation of PS-Ca21 complexes into crystalline domains.
There was no evidence, as detected by freeze-fracture, for
the presence of crystalline domains, which give rise to
characteristic freeze-fracture morphology. Second, the 31P
NMR spectra arising from the DOTMA/DOPE vesicles in
the presence of plasmid are not consistent with lateral
segregation of the DOTMA component. Specifically, if the
DOTMA component was appreciably laterally segregated,
DOPE would be expected to revert to the HII phase orga-
nization it adopts in isolation at high plasmid levels. This is
not observed (Fig. 3 A). It should be noted that this behavior
contrasts with the behavior of the DOTMA/DOPC systems
in the presence of plasmid DNA. In this case, the ability of
plasmid to cause fusion resulting in DOPC in the bilayer
organization it adopts in isolation is fully consistent with
sequestration of the DOTMA by the plasmid. This is also
consistent with recent work by Mitrakos and Macdonald
(1996), who describe the ability of polyadenylic acid to
sequester cationic lipids in mixtures with PC.
Lipid mixing studies characterizing fusion of cationic
vesicles induced by monovalent and multivalent anions
have been reported previously (Rupert et al., 1985; Stama-
tatos et al., 1988; Duzgunes et al., 1989). This includes
oligonucleotides (Jaaskelainen et al., 1994) as well as
genomic DNA (Gershon et al., 1993). The studies presented
here allow a comparison of the potency of plasmid DNA
with anions of different valence. The high potency of
pCMV5 plasmid DNA for fusing DOTMA/DOPE LUVs as
compared to chloride or citrate anions can be attributed to
cationic surfaces, as well as an ability of the DNA polymer
to cross-link vesicles, thus directly promoting aggregation.
This aggregation potential is observed at low plasmid levels
in DOTMA/DOPE systems (Fig. 4 B), where the formation
of small clusters precedes the formation of highly fused
complexes. Lipid mixing studies demonstrating fusion be-
tween cationic and anionic vesicles have also been reported
previously (Stamatatos et al., 1988; Duzgunes et al., 1989;
Bailey and Cullis, 1997). The main point of the studies
presented here concerns the ability of high levels of plasmid
DNA to inhibit fusion between DOTMA/DOPE systems
and anionic (DOPS/DOPC) systems. This is fully consistent
with charge repulsion effects inhibiting interactions be-
tween the DNA-cationic lipid complexes and negatively
charged vesicles. Related effects have been observed for
oligonucleotide-cationic lipid complexes (Jaaskelainen et
al., 1994). Such effects are also consistent with the inhibi-
tion of transfection at high plasmid DNA-to-cationic lipid
levels (Fig. 12), which presumably reflect reduced associa-
tion with target cells.
The nature of the complexes formed on the addition of
plasmid DNA to DOTMA/DOPE vesicles and the relation
between this structure and transfection potential is of im-
portance. Previous studies on the relation between the struc-
ture of cationic lipid-plasmid DNA complexes and transfec-
tion potential have focused primarily on morphology as
detected by electron microscopy techniques. The work of
Stemnberg et al. (1994) suggests that transfection potency
correlates with the presence of long strands of DNA encap-
sulated in tubules of lipid. Such structures were not ob-
served in the freeze-fracture studies performed here, al-
though lipidic particle structures associated with nonbilayer
lipid structures were observed, as also reported by Stemnberg
et al. (1994). As indicated below, the presence of nonbilayer
lipid structure is consistent with the 31P NMR studies.
The most striking result of the studies presented here is
that the more potent transfection systems contain lipid in
large structures that allow significant isotropic motional
averaging. The nonfractionated DOTMA/DOPE complexes
formed with plasmid DNA exhibit a narrow isotropic 31p
NMR signal, whereas considerably broader bilayer 31P
NMR spectra are observed for the DOTMA/DOPC systems
in the presence of similar levels of plasmid. The isotropic
signal observed for the nonfractionated plasmid-DOTMA/
DOPE complexes with high transfection ability cannot be
attributed to small vesicular structures, as the fusion, light
scattering, and freeze-fracture studies reveal the presence of
large, highly fused, lipid aggregates. In the case of the
system fractionated by centrifugation, the 31P NMR reso-
nance observed for the DOPE-containing system is broader
but remains significantly narrower than that of nontransfect-
ing counterparts containing DOPC. Isotropic 31P NMR sig-
nals are characteristic of lipid dispersions that form nonbi-
layer structures such as cubic or other inverted phases
(Cullis and de Kruijff, 1979; Ellens et al., 1989; Lindblom
and Rilfors, 1989), and variants such as interlamellar attach-
ment sites may play direct roles in membrane fusion phe-
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nomena (Siegel et al., 1989). Such lipid organization could
promote fusion or membrane destabilization after interac-
tion with target cell membranes. The available evidence
suggests that destabilization of the endosomal membrane is
a dominant route for cationic liposome-mediated transfec-
tion (Farhood et al., 1995; Wrobel and Collins, 1995; Zab-
ner et al., 1995; Friend et al., 1996; Xu and Szoka, 1996).
The results presented here suggest that nonbilayer lipid
structures could play a direct role in this process, thus
facilitating the transfection event.
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